By THE ASSOCIATED PRESSAUG. 28, 2015
Mylan shareholders approved the company’s hostile pursuit of Perrigo, and the company hopes to push ahead with a formal offer soon. Perrigo, which makes over-the-counter medicines, has resisted repeated overtures. In a statement, Perrigo said it was confident that its shareholders would reject the offer from Mylan, a generic drug maker. A combination of the two companies would create one of the world’s largest makers of generic and over-the-counter medications. Perrigo rejected an offer in April of about $34.1 billion in cash and stock.A version of this brief appears in print on August 29, 2015, on Page B2 of the New York edition with the headline: Mylan Gets Shareholders’ Blessing to Buy Perrigo.  Order Reprints| Today's Paper|Subscribe

We’re interested in your feedback on this page. Tell us what you think.